Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124248582 | 12424858 | 2 | F | 20160725 | 20160601 | 20160805 | EXP | US-PFIZER INC-2016283500 | PFIZER | LIGGINS, C.A.. SERTOLI-LEYDIG CELL TUMOR OF THE OVARY: A DIAGNOSTIC DILEMMA. GYNECOLOGIC ONCOLOGY REPORTS. 2016;15:16-19 | 40.00 | YR | F | Y | 0.00000 | 20160805 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124248582 | 12424858 | 1 | PS | PACLITAXEL. | PACLITAXEL | 1 | 2 CYCLES | 76131 | |||||||||||
| 124248582 | 12424858 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | 2 CYCLES | 76517 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124248582 | 12424858 | 1 | Ovarian Sertoli-Leydig cell tumour |
| 124248582 | 12424858 | 2 | Ovarian Sertoli-Leydig cell tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124248582 | 12424858 | OT |
| 124248582 | 12424858 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124248582 | 12424858 | Abdominal pain | |
| 124248582 | 12424858 | Herpes zoster | |
| 124248582 | 12424858 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |